GeneDx Holdings Corp.: Deep Track Capital, LP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Deep Track Capital, LP disclosed a stake exceeding 5% in GeneDx Holdings Corp. via a Schedule 13G filing with the SEC (accession 0001172661-26-005472). The exact share count and percentage were not specified in the filing headline. The move signals new institutional interest in the genetic testing company. Investors will watch whether Deep Track pushes for strategic changes or remains a passive holder.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
GeneDx Holdings Corp., Deep Track Capital, LP